Naloxegol
Basic Information
| Item | Value |
|---|---|
| DrugBank ID | DB09049 |
| Evidence Level | L5 (Computational Prediction) |
| Number of Predicted Indications | 10 |
Predicted Indications (TxGNN)
The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.
| # | Indication | Source |
|---|---|---|
| 1 | nephrogenic syndrome of inappropriate antidiuresis | KG + DL |
| 2 | acute intermittent porphyria | KG + DL |
| 3 | insomnia (disease) | KG + DL |
| 4 | carbamoyl phosphate synthetase I deficiency disease | KG + DL |
| 5 | hypertrichosis (disease) | KG + DL |
| 6 | hyperargininemia | KG + DL |
| 7 | malformation syndrome with odontal and/or periodontal component | KG + DL |
| 8 | syndrome with a Dandy-Walker malformation as major feature | KG + DL |
| 9 | Ambras type hypertrichosis universalis congenita | KG + DL |
| 10 | isolated genetic hair shaft abnormality | KG + DL |
Disclaimer
These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.